Lafutidine
From Self-sufficiency
250px | |
Systematic (IUPAC) name | |
---|---|
2-[(2-furylmethyl)sulfinyl]-N-((2Z)-4-{[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxy}but-2-en-1-yl)acetamide | |
Clinical data | |
Routes of administration | Oral |
Identifiers | |
CAS Number | 118288-08-7 |
ATC code | A02BA08 (WHO) |
PubChem | CID 5282136 |
Chemical data | |
Formula | C22H29N3O4S |
Molar mass | 431.54 g/mol[[Script error: No such module "String".]] |
Lafutidine (INN) is a H2 receptor antagonist.
45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- H2 receptor antagonists
- Piperidines
- Pyridines
- Phenol ethers
- Alkenes
- Acetamides
- Furans
- Gastrointestinal system drug stubs